Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Belmont Diagnostics logo — SpotOnMe provides fast, simple, and affordable plasma extrac...

Belmont Diagnostics

SpotOnMe provides fast, simple, and affordable plasma extraction from just a drop of blood, opening the door to a vast array of tests.

1 employees Non Equity Assistance Biotechnology, Medical Devices

General Information

Company Name Belmont Diagnostics
Employees 1
Industries Biotechnology, Medical Devices
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with Belmont Diagnostics. To contact Belmont Diagnostics, visit belmontdiagnostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Belmont Diagnostics

Belmont Diagnostics is a biotechnology startup that has developed the SpotOnMe device, with the slogan "SpotOnMe provides fast, simple, and affordable plasma extraction from just a drop of blood, opening the door to a vast array of tests." The SpotOnMe device is designed to extract quality plasma from a drop of blood faster, easier, and more cost-effectively than any other existing methods, and it has the potential to make a significant impact in the field of biotechnology. The company recently received a Non Equity Assistance investment on 02 January 2023, with Incubateur Impulse being the contributing investor. With this support, Belmont Diagnostics has the opportunity to further develop and market the SpotOnMe device, potentially revolutionizing the accessibility of a wide range of tests that can be conducted using plasma extracted through their innovative technology.

Taxonomy: plasma extraction, diagnostics device, blood testing, biotech startup

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
Incubateur Impulse
Incubateur Impulse
02 Jan 2023

Belmont Diagnostics Alternatives & Competitors

View All Alternatives
Belmont Diagnostics vs
SpinChip Diagnostics ASA
SpinChip Diagnostics ASA Norway

SpinChip Diagnostics is a medical device company that is developing a game changing and proprietary...

Venture round
60 employees
Biotechnology, Health Care
Belmont Diagnostics vs
Haemokinesis
Haemokinesis Australia

When every second counts.

34 employees
Biotechnology, Health Care
Belmont Diagnostics vs
Truvian
Truvian United States

blood testing anyone. anywhere.

Venture round
108 employees
Biotechnology, Health Care
View all alternatives

FAQ About Belmont Diagnostics

SpotOnMe provides fast, simple, and affordable plasma extraction from just a drop of blood, opening the door to a vast array of tests.
Belmont Diagnostics operates in Biotechnology and Medical Devices. Its work centres on plasma extraction, diagnostics device, blood testing and biotech startup.
Belmont Diagnostics has approximately 1 employees.
Belmont Diagnostics has completed 1 funding round. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to Belmont Diagnostics include SpinChip Diagnostics ASA, Haemokinesis, Truvian, Sigrid Therapeutics, Haemonetics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Belmont Diagnostics and SpinChip Diagnostics ASA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Belmont Diagnostics, https://bouncewatch.com/company/belmont-diagnostics, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes